Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A J Olyaei

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Drugs|January 29, 2000
A practical guide to the management of hypertension in renal transplant recipientsA J Olyaei, A M deMattos, W M Bennett
Current Opinion in Nephrology and Hypertension|September 16, 2000
Renal toxicity of protease inhibitorsA J Olyaei, A M deMattos, W M Bennett
Drug Safety|June 1, 1997
Switching between cyclosporin formulations. What are the risks?A J Olyaei, A M deMattos, W M Bennett
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 17, 2000
Nephrotoxicity of immunosuppressive drugs: long-term consequences and challenges for the futureA M de Mattos, A J Olyaei, W M Bennett
Current Opinion in Critical Care|January 24, 2002
Nephrotoxicity of immunosuppressive drugs: new insight and preventive strategiesA J Olyaei, A M de Mattos, W M Bennett
Drug Safety|December 28, 1999
Immunosuppressant-induced nephropathy: pathophysiology, incidence and managementA J Olyaei, A M de Mattos, W M Bennett
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 1, 1996
Pharmacology of immunosuppressive medications used in renal diseases and transplantationA M de Mattos, A J Olyaei, W M Bennett
Drugs of Today (Barcelona, Spain : 1998)|March 11, 2004
Pharmacology of immunosuppressive drugsA J Olyaei, A M de Mattos, W M Bennett
Progress in Transplantation (Aliso Viejo, Calif.)|May 19, 2001
Use of basiliximab and daclizumab in kidney transplantationA J Olyaei, K Thi, A M deMattos, et al.
Pharmacotherapy|December 17, 1998
Interaction between tacrolimus and nefazodone in a stable renal transplant recipientA J Olyaei, A M deMattos, D J Norman, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Drugs|January 29, 2000
A practical guide to the management of hypertension in renal transplant recipientsA J Olyaei, A M deMattos, W M Bennett
Current Opinion in Nephrology and Hypertension|September 16, 2000
Renal toxicity of protease inhibitorsA J Olyaei, A M deMattos, W M Bennett
Drug Safety|June 1, 1997
Switching between cyclosporin formulations. What are the risks?A J Olyaei, A M deMattos, W M Bennett
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 17, 2000
Nephrotoxicity of immunosuppressive drugs: long-term consequences and challenges for the futureA M de Mattos, A J Olyaei, W M Bennett
Current Opinion in Critical Care|January 24, 2002
Nephrotoxicity of immunosuppressive drugs: new insight and preventive strategiesA J Olyaei, A M de Mattos, W M Bennett
Drug Safety|December 28, 1999
Immunosuppressant-induced nephropathy: pathophysiology, incidence and managementA J Olyaei, A M de Mattos, W M Bennett
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 1, 1996
Pharmacology of immunosuppressive medications used in renal diseases and transplantationA M de Mattos, A J Olyaei, W M Bennett
Drugs of Today (Barcelona, Spain : 1998)|March 11, 2004
Pharmacology of immunosuppressive drugsA J Olyaei, A M de Mattos, W M Bennett
Progress in Transplantation (Aliso Viejo, Calif.)|May 19, 2001
Use of basiliximab and daclizumab in kidney transplantationA J Olyaei, K Thi, A M deMattos, et al.
Pharmacotherapy|December 17, 1998
Interaction between tacrolimus and nefazodone in a stable renal transplant recipientA J Olyaei, A M deMattos, D J Norman, et al.
Pageof 3